Treating Hepatitis C in Patients with HIV Disease

CME Certificate Fee: $25.00 (USD) for certificate

Optional Maintenance of Certification Credit (MOC) Fee: $10.00 (USD) per point

1.00 AMA PRA Category 1 Credit(s)^TM

1.00 Part II MOC points are available for these specialty board(s):

American Board of Internal Medicine

Credit Type: Medical Knowledge

Practice Areas: Infectious Disease

Estimated time to complete this activity: 1.00 hours

Author(s)/Editor(s): Stephen Klotz, MD
DISCLOSURE STATEMENT: All author(s), contributor(s), editor(s), and CME Office Reviewer(s) state that they do not have any financial arrangements with commercial interests that could constitute a conflict of interest.
Further Author/Editor Information | Further CME Information

Meets Special CME Requirements in: Connecticut, Florida Learn More >>

Outcome Objectives:

As a result of completing this activity, the participant will be better able to:

Diagnose the clinical syndrome of porphyria cutanea tarda.
Diagnose hepatitis C.
Adjust the treatment of hepatitis C based on viral genotype and liver pathology.

Learning Format: Case-based, interactive online course, including mandatory assessment questions (number of questions varies by course or module). Please also read the Technical Requirements.

CME Sponsor: University of Arizona College of Medicine - Tucson
Credit Designation and Accreditation Statements >>

Current CME Approval Period: October 20, 2021 - October 19, 2024

Original Release Date: October 20, 2006

Most Recent Review by Author: October 20, 2021

Most Recent Review by CME Sponsor: October 20, 2021

Financial Support Received: None

Treating Hepatitis C in Patients with HIV Disease

1.00 AMA PRA Category 1 Credit(s)^TM

1.00 Part II MOC points are available for these specialty board(s) (Optional):

American Board of Internal Medicine

Credit Type: Medical Knowledge

Practice Areas: Infectious Disease

Current CME Approval Period: October 20, 2021 - October 19, 2024

Financial Support Received: None

ACCME/AMA PRA Accreditation Statement

The University of Arizona College of Medicine - Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Arizona College of Medicine - Tucson designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Office Contact Information and CME Disclosure

The University of Arizona College of Medicine - Tucson
Office of Continuing Medical Education
520-626-7832
uofacme@email.arizona.edu

The following University of Arizona College of Medicine - Tucson CME Reviewers, Activity Directors, or Planning Committee Members have no relevant financial relationships with commercial interests that could constitute a conflict of interest with the proposed activity:

Robert Amend, M.Ed.
Randa Kutob, MD

MOC Recognition Statement(s)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge Part II MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

If you elect to receive MOC credit for this course, you give permission for VLH.com to share your information and activity completion data with the ACCME and the specialty board(s) chosen through the ACCME's Program and Activity Reporting System (PARS).

Treating Hepatitis C in Patients with HIV Disease

About the Author

Stephen A. Klotz, M.D.

Stephen A. Klotz, MD is Professor of Medicine and Director of the Fellowship Program, Section of Infectious Diseases, University of Arizona School of Medicine and the Southern Arizona Veterans Affairs Health Care System, Tucson, Arizona. He is the Director of the Special Immunology Program (HIV) at the university. He maintains an active laboratory studying the molecular interactions of Candida albicans with human proteins and cells.

Disclosure: Dr. Klotz states that he does not have any financial arrangements that could constitute a conflict of interest.

Treating Hepatitis C in Patients with HIV Disease

Ratings (418 responses)


How would you rate this program overall? Average Rating: 4.00/5.00

How well were the learning objectives of this program met? Average Rating: 4.26/5.00


User Comments


by Hidden \| Mar 28, 2021 none

by rigoberto franco \| Nov 15, 2018 very good

by Hidden \| Sep 27, 2016 excellent course and case review especially with the patient presentation of PCT leading to diagnosing Hepatitis C

by HUGO ESPINOSA \| Jan 19, 2015 read your own XRAY !!!

by Hidden \| Jun 10, 2014 Helpful information

by Hidden \| Jan 30, 2014 The course was well done and appropriate. As a radiologist my main role in managing these patients is in performing the liver biopsies and in evaluating MR, CT and US of the liver looking for evidence of development of hepatocellular carcinoma. In the example the liver biopsy was performed by a gastroenterologist, but we do plenty of them in radiology!

Treating Hepatitis C in Patients with HIV Disease

This course meets general AMA PRA Category 1 CME Credit(s)^TM requirements in states that have a CME requirement.

Based on information from state licensing authorities, this program meets special CME requirements in these states:

	Connecticut Infectious Diseases CME
	Florida HIV/AIDS CME

View other courses meeting Special State Requirements

Treating Hepatitis C in Patients with HIV Disease

Technical Requirements

This web-based activity is offered online and requires an always-on connection to the Internet (the activity cannot be downloaded). The activity works on PC or Mac computers and most tablet computers. The activity should work with the newer versions of major Internet browsers, including Edge, Chrome, Safari, and Firefox. JavaScript should be enabled in all browsers, and Popups and first party cookies need to be accepted from www.VLH.com. You should also have the latest, free Adobe Reader installed for reading documents.

For additional information, read the Technical Assistance FAQ.